<DOC>
	<DOCNO>NCT00262496</DOCNO>
	<brief_summary>The purpose study determine whether Botulinum-A toxin inject bladder muscle help prevent frequency degree urinary incontinence Spinal Cord Injured Multiple Sclerosis patient . The propose mechanism would Toxin would allow bladder hold urine low pressure determine Urodynamics . The research answer question whether dosage 300 unit vs 400 unit either equally vs equally effective help urinary incontinece bladder storage .</brief_summary>
	<brief_title>Botulinum-A Toxin Injection Detrusor Hyperreflexia Spinal Cord Injury : A Non-Surgical Approach .</brief_title>
	<detailed_description>OBJECTIVE OF THE PROJECT The major aim present study use double blind randomize clinical trial design evaluate long-term efficacy safety two different dos , 300 400 Units Botulinum Toxin Type-A treatment detrusor hyperreflexia ( Neurogenic Bladder Overactivity ) . While also improve bladder capacity spinal cord injure patient refractory symptom fail anticholinergic agent . RESEARCH PLAN Inclusion Criteria : Male female subject 18-80 year age suprasacral SCI refractory NBOA incontinence , and/or impaired detrusor compliance associate small bladder capacity eligible . Subjects recruit basis incontinence symptom adverse urodynamic parameter include impaired bladder compliance less 50ml/cm , H20 bladder ( cystometric ) capacity le 300 ml . Exclusion criterion : Allergy Botulinum Toxin Type-A , pregnancy , breast-feeding woman , active medical psychiatric disorder , active urinary tract infection , coagulopathy , myasthenia gravis , upper urinary tract change unrelated low tract dysfunction , aminoglycoside use last three month . Furthermore , subject radiation cystitis ( history ) , vesico-ureteral reflux ( videofluoroscopy ) , bladder calculus ( cystoscopy ) exclude . Evaluation include history physical examination , urine analysis , urine culture sensitivity , 24-hour void diary 3 consecutive day , urine pregnancy test female subject reproductive age , validated questionnaire , multichannel videourodynamics ( UDS ) , post-void residual volume time UDS , renal ultrasound . METHODOLOGY One week pre-intervention evaluation , endoscopic injection Botulinum Toxin Type-A ( 300 Units 400 Units ) detrusor muscle perform . During 24 month duration study , participant take record regular bladder medication Dr. Gousse ( one assistant ) decide necessary control urinary symptom . Subjects schedule return 2 , 6 , 12 week first injection session , every 3 month thereafter . At 2-week visit ass untoward effect . At 6-week visit every subsequent visit focus physical examination carry , along validated questionnaire . Participants initial success , define 50 % improvement ( void diary ) diminish leakage , improve cystometric capacity great 100 ml , improve compliance 15 ml/cm H20 , 50 % improvement questionnaire score , lose initial therapeutic benefit consider candidate re-injection every 6 month . Patients continue maintain therapeutic benefit pas 6 month initial injection re-injected re-evaluated every 3 month thereafter prior possible re-injection . Pregnancy test obtain prior injection session appropriate female subject reproductive year . Depending type variable analyzed different statistical technique use comparison include paired sample t-tests , Wilcoxon 's signed rank test , McNemar 's test , Cochran 's Q test . Cross-sectional well longitudinal analysis perform compare 300 vs. 400 Unit group respect variable ascertain time point , also respect change time major study end point .</detailed_description>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Reflex , Abnormal</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Patients must 1880 year old suprasacral spinal cord injury ( SCI ) multiple sclerosis ( MS ) refractory Neurogenic bladder overactivity and/or detrusor compliance associate small bladder capacity.· Impaired bladder compliance le 50 ml/cm , H2O bladder ( cystometric ) capacity less 300ml . Allergy Botulinum Toxin TypeA· Pregnancy· Breastfeeding women· Active medical psychiatric disorders· Upper urinary tract change unrelated low tract dysfunction· Aminoglycoside use last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Botox</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>Incontinence</keyword>
	<keyword>Spinal Cord Injury</keyword>
</DOC>